Glioblastoma Relapses Show Increased Markers of Vulnerability to Ferroptosis

BACKGROUND: Despite the availability of various therapy options and being a widely focused research area, the prognosis of glioblastoma (GBM) still remains very poor due to therapy resistance, genetic heterogeneity and a diffuse infiltration pattern. The recently described non-apoptotic form of cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Kram, Helena, Prokop, Georg, Haller, Bernhard, Gempt, Jens, Wu, Yang, Schmidt-Graf, Friederike, Schlegel, Jürgen, Conrad, Marcus, Liesche-Starnecker, Friederike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071304/
https://www.ncbi.nlm.nih.gov/pubmed/35530303
http://dx.doi.org/10.3389/fonc.2022.841418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071304/
https://www.ncbi.nlm.nih.gov/pubmed/35530303
http://dx.doi.org/10.3389/fonc.2022.841418

Ejemplares similares